Bispecific T cell engager therapy for refractory rheumatoid arthritis.
Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D'Agostino MA, Schett G, Grieshaber-Bouyer R.
Bucci L, et al. Among authors: d agostino ma.
Nat Med. 2024 Apr 26. doi: 10.1038/s41591-024-02964-1. Online ahead of print.
Nat Med. 2024.
PMID: 38671240